Subscribe to Newsletter
Manufacture Vaccines

Cancer Vaccines: Activate the Immunosoldiers – Part I

| 11 min read

What’s all this talk of cancer vaccines? We find out how they work – and how mRNA has boosted the field – with the help of five experts.
Discovery & Development Drug Delivery

Managing Change in Devices for Patients

| Alex Fong | 4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want.
Manufacture Contract Manufacturing Services

Wegovy and Ozempic: Shortages, CDMO Controversy… And Bernie Sanders

| Stephanie Vine | 5 min read

Why GLP-1 anti-obesity drugs are taking the market by storm.
Manufacture Small Molecules

Another Chance for Arsenic

| Carole Nicco | 4 min read

The repurposing of legacy small molecules drugs could be more advantageous than previously known. Case in point: Arsenic

Business & Regulation Profession

Sitting Down With… The Past: Jane Osbourn

| 2 min read

We dive into the archive of 2020 for insight and inspiration – this time with Jane Osbourn.
Manufacture Small Molecules

Moving with the Times

| Julian Northen | 6 min read

Patient needs are changing, but small molecule drugs remain as important as ever. Here are some tips for development success.
Discovery & Development Clinical Trials

The Art of Prescreening

| 5 min read

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.
Business & Regulation Trends & Forecasts

Achema Day 4: Looking to a Greener Future

| 3 min read

Our quick guide to day 4 at Achema.
Business & Regulation Trends & Forecasts

Flow Chemistry and Nanotechnology Shine at Achema Day 3

| 3 min read

The Flow Chemistry Symposium kicks off at Achema today. Here’s what else to look forward to.
Discovery & Development Clinical Trials

Don’t Forget the Elderly

| Sharmeen Roy | 4 min read

Older adults are underrepresented in clinical trials. This needs to change.
Discovery & Development Drug Discovery

Meet the Goldilocks Molecules

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 2

Discovery & Development Formulation

Schizophrenia and the Future of Long-Acting Therapeutics

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker